Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03036930 · ClinicalTrials.gov registry record · Phase 2
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
A Phase 2 study of Human Papillomavirus Infection and Human Papillomavirus-Related Carcinoma, sponsored by National Cancer Institute (NCI).
- Active
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
- 6
- Study locations
NCT03036930 is a Phase 2 study of Human Papillomavirus Infection and Human Papillomavirus-Related Carcinoma that is active but no longer recruiting, run by National Cancer Institute (NCI). The registered enrollment target is 51 participants, below the 1,316-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT03036930, a Phase 2 study of Human Papillomavirus Infection and Human Papillomavirus-Related Carcinoma, is active but no longer recruiting, sponsored by National Cancer Institute (NCI).
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
- 6
- Study locations
Study Summary
This phase II trial studies whether the nonavalent human papillomavirus vaccine given to adults prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent transplant rejection. This study will help inform our scientific understanding about vaccine-induced immune responses among immunosuppressed individuals.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Questionnaire Administration
- BIOLOGICAL Recombinant Human Papillomavirus Nonavalent Vaccine
- PROCEDURE HPV Self-Collection
Study Locations (6)
California
- Cedars Sinai Medical Center - Los Angeles
- UCSF Medical Center-Mount Zion - San Francisco
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
Illinois
- Northwestern University - Chicago
Minnesota
- Mayo Clinic in Rochester - Rochester
North Carolina
- UNC Lineberger Comprehensive Cancer Center - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2017-06-23 |
| Est. Completion | 2026-03-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03036930
The ClinicalTrials.gov registry entry for NCT03036930 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,316-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target (96% lower). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Human Papillomavirus Infection appearing as the primary indexed condition, and to 4 interventions - of which Biospecimen Collection is the first listed.
NCT03036930 reports 6 study locations spanning 5 distinct geographic areas - top geographies include California, Alabama, Illinois.
Frequently Asked Questions
What is clinical trial NCT03036930 about?
NCT03036930 is a clinical study titled "Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients". This phase II trial studies whether the nonavalent human papillomavirus vaccine given to adults prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent transplant rejectio...
What is the current status of trial NCT03036930?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2017-06-23. Estimated completion is 2026-03-06.
What conditions does trial NCT03036930 study?
This clinical trial studies the following conditions: Human Papillomavirus Infection, Human Papillomavirus-Related Carcinoma.
What interventions are being tested in trial NCT03036930?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Questionnaire Administration (OTHER), Recombinant Human Papillomavirus Nonavalent Vaccine (BIOLOGICAL), HPV Self-Collection (PROCEDURE).
Who is sponsoring clinical trial NCT03036930?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03036930 being conducted?
This trial has 6 study locations across Alabama, California, Illinois, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer
COMPLETED · Phase 2
-
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Human Papillomavirus Infection
All registered trials for this condition
Human Papillomavirus-Related Carcinoma
All registered trials for this condition
Alabama
All trials with a study site in Alabama
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.